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In this study, intact flagellin proteins were purified from strains of Clostridium difficile and analyzed using
quadrupole time of flight and linear ion trap mass spectrometers. Top-down studies showed the flagellin
proteins to have a mass greater than that predicted from the corresponding gene sequence. These top-down
studies revealed marker ions characteristic of glycan modifications. Additionally, diversity in the observed
masses of glycan modifications was seen between strains. Electron transfer dissociation mass spectrometry was
used to demonstrate that the glycan was attached to the flagellin protein backbone in O linkage via a HexNAc
residue in all strains examined. Bioinformatic analysis of C. difficile genomes revealed diversity with respect to
glycan biosynthesis gene content within the flagellar biosynthesis locus, likely reflected by the observed
flagellar glycan diversity. In C. difficile strain 630, insertional inactivation of a glycosyltransferase gene
(CD0240) present in all sequenced genomes resulted in an inability to produce flagellar filaments at the cell
surface and only minor amounts of unmodified flagellin protein.
Clostridium difficile, a gram-positive, anaerobic, spore-forming
bacterium, is an emerging opportunistic pathogen and the leading
cause of antibiotic-associated diarrhea and pseudomembranous
colitis in humans. The recent emergence of the hypervirulent
NAP1/027 strain in hospitals of North America has resulted in
increased mortality rates (18, 19). While previous reports of C.
difficile epidemics were restricted to single institutions or wards,
more recently, there appears to be a wider distribution of out-
breaks (20), accompanied by increasing severity of disease as well
as a significant increase in the numbers of case fatalities reported
(21). The pathogen is most frequently associated with antibiotic
treatment, which disrupts the gut flora, allowing C. difficile to
colonize and multiply (16). Extensive studies have demonstrated
that two toxins, TcdA and TcdB, are responsible for severe tissue
damage and consequent manifestation of disease (34). Infection
with C. difficile can lead to severe diarrhea, abdominal pain, and
further complications, such as pseudomembranous colitis, inflam-
mation, and ulceration of the lining of the intestinal wall (5, 16).
Importantly, recurrence rates following treatment can be as high
as 35% irrespective of the drug used in initial treatment (10, 35).
The estimated incidence in Canadian hospitals ranges from 38 to
95 cases per 100,000 patients (1), while in the United States, the
estimated number of cases of C. difficile disease exceeds 250,000/
year (36), with related health care costs of $1 billion annually (16).
While prevention through antibiotic stewardship and optimal
management of disease is the most obvious strategy currently
used, there is a great need for alternate methods of treatment.
Prior to the production and release of toxin, the organism
must germinate from a recalcitrant spore form and proceed to
colonize the gastrointestinal tract. This colonization process is
an important first step in the disease process, whereby the
organism penetrates the mucus layer and adheres to the un-
derlying colonic epithelial cells, thereby facilitating the delivery
of toxins to host cell receptors. Adhesion, an early critical step
in colonization, involves a number of virulence factors, but the
precise mechanisms by which bacteria adhere to the mucosa
and initiate infection remain to be elucidated. Such adhesins
include the flagellum (29) and the high-molecular-weight sur-
face layer protein (6). C. difficile is known to express peritri-
chous flagella, and it has been observed that the level of ad-
herence of flagellated strains to the mouse cecum is 10-fold
higher than the level of adherence of nonflagellated strains
(29).
The flagellum plays a role in the ability of bacteria to adapt
to their unique biological niches. Flagella from a wide range of
bacteria have been shown to be important as both colonization
and virulence factors, as well as critical to biofilm formation in
many species (3, 37). In recent years, a rapidly increasing body
of work has described the process of flagellar glycosylation in
a diverse number of bacterial species (reviewed in reference
17). The diversity of glycan structures found on these organ-
isms from unique environments points to a novel biological
role for the respective glycans, which has yet to be revealed. In
some cases, it has been demonstrated that the process of flagel-
lar glycosylation has a role in both flagellar assembly and host-
pathogen interactions (17). In Campylobacter spp., for exam-
ple, in addition to being required for flagellar assembly,
flagellar glycosylation plays a role in autoagglutination prop-
erties of cells and subsequent virulence and contributes to
antigenic specificity (11). The sites of glycosylation of flagellin
monomers from a diverse number of bacterial species have all
been shown to reside within the two surface-exposed domains
(denoted D2 and D3) of the flagellin monomer when assem-
bled within the flagellar filament (22). Structural analysis of
Salmonella enterica flagellin has revealed that these regions are
surface exposed in the assembled filament and, hence, are well
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positioned to facilitate a myriad of extracellular interactions
with either host cells or environmental substrates.
Many of the studies of bacterial flagellar glycosylation have
focused upon gram-negative organisms. Of the motile gram-
positive bacteria, flagellin from Listeria monocytogenes has
been shown to be glycosylated with -O-linked GlcNAc at up
to six sites/flagellin (23). The flagellins of Clostridium botuli-
num have also been reported to be glycosylated with le-
gionaminic or hexuronic acid derivatives (32), and preliminary
evidence for glycosylation of C. tyrobutyricum flagellin has been
reported (4). However, a functional role for glycosylation has
yet to be revealed for any of these organisms. It has been
reported that purified C. difficile flagellin monomers from var-
ious strains migrate at a molecular weight greater than that
predicted from the translated DNA sequence, but flagellin
monomers showed no reactivity with standard glycan staining
kits (31).
In this study, we show that flagellins of C. difficile strain 630
as well as those from recent clinical isolates of C. difficile are
modified with diverse O-linked glycan moieties. In addition, we
have identified through mutagenesis a glycosyltransferase gene
from the flagellar biosynthesis locus; it is involved in the gly-
cosylation process and, upon inactivation, leads to loss of sur-
face-associated flagellin protein.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The C. difficile isolates examined in
this study are presented in Table 1. All strains examined in this study, with the
exception of QCD32g58, M7465, and M9349, do not appear to be clonally
related. They are from distinct outbreaks and display unique typing profiles.
Strains were grown on brain heart infusion (BHI) agar media supplemented with
0.5 g liter1 cysteine-HCl, 5 mg liter1 hemin, 1 mg liter1 vitamin K1, and 1 mg
liter1 resazurin. Bacteria were grown under anaerobic conditions at 37°C in
anaerobe chambers using Oxoid Anaerobe Paks.
Motility assays. Motility assays were performed using motility agar tubes
containing BHI medium (0.175% agar). These were stab inoculated and grown
anaerobically at 37°C for 48 h (30).
Flagellin protein purification. Flagellin proteins were isolated using the fol-
lowing procedure. Strains were grown on supplemented BHI plates under an-
aerobic conditions for 24 h. Bacteria were harvested in 500 l distilled water and
vortexed for 3 min before being centrifuged at 14,000 rpm in a benchtop cen-
trifuge for 5 min. The supernatants were lyophilized and resuspended in 100 l
of distilled water.
S-layer protein extraction. Partially purified S-layer was obtained from C.
difficile cells by resuspending growth from a single BHI plate (24 h) in 500 l of
0.2 M glycine buffer, pH 2.2. After 5 min, the bacterial cells were removed from
the glycine buffer by centrifugation and supernatant retained. The glycine buffer
of this partially purified S-layer preparation was exchanged with distilled water
using an Amicon Ultra 4 centrifugal filter (Millipore Corp, Billerica, MA). These
S-layer samples were then used in solution enzyme digests as described below.
MS of isolated flagellins. Purified flagellin was exchanged into aqueous 0.2%
formic acid (vol/vol) by using a Centricon YM-30 membrane filter (Millipore).
The resulting solution was infused in a hybrid quadrupole time of flight mass
spectrometer (MS) (QTOF2; Waters, Beverly, MA) at a flow rate of 0.5 l
min1. Reconstructed molecular mass profiles of intact proteins were obtained
through spectral deconvolution using MaxEnt (MassLynx software; Waters, Bev-
erly, MA). Top-down experiments were performed as described by Schirm et al.
(24) by using argon collision gas with collision energies ranging from 20 to 30 V.
RF lens 1 voltage was increased from 30 to 125 V in order to obtain second-
generation-fragment ion spectra. Tandem MS (MS/MS) of glycan-related ions
was then carried out on glycan-related fragment ions generated in the orifice/
TABLE 1. Diversity of glycan modifications among C. difficile strains
Strain Origin/type(s) Predicted mass(Da)a
Accurate mass
(Da)b
Glycan mass(es) (predicted
monosaccharide compositions) (Da)c
% Peptide
sequence
coveraged
Sites of
modificatione
630 Epidemic type X, 012 ribotype, A B 30,773 33,559, 33,160 398 (203, 98, 115) 94 S141, S174, T183
S188, S205
BI-1 Fluoroquinone sensitive, toxinotype 3,
nonepidemic, Minneapolis, MN,
1988
30,901 35,106, 35,473,
35,841, 36,208,
37,166
509 (203, 146, 160), 523 (203, 160, 160),
890 (203, 146, 146, 192, 203)
88 T141, S174, S205
BI-7 Fluoroquinone resistant, toxinotype 3,
epidemic, Portland, OR, 2003
30,901 NDf 509, 523 (203, 160, 160), 890 (203, 146,
146, 192, 203)
ND T141, S174, S205
QCD32g58 Toxinotype 0, Quebec, Canada 30,901 ND ND ND ND
M7465 Toxinotype 0, Quebec, Canada, 2005 30,901 35,083, 35,465,
35,849
523 (203, 160, 160), 904 (203, 160, 146,
192, 203), 890 (203, 146, 146, 192,
203), 509
65 T141, S174, S205
M9349 Toxinotype 0, Quebec, Canada, 2005 30,901 33,862, 35,082,
35,463, 35,840
509, 523 (203, 160, 160), 890 (203, 146,
146, 192, 203)
60 T141, S174, S205
CM-56 A B, Manitoba, Canada, 2000, 20
cases
30,919 ND 523 (203, 160, 160), 904 (203, 160, 146,
192, 203), 890 (203, 146, 146, 192,
203), 509
60 T141, S174, S205
M46846 Toxinotype 9, Quebec, Canada, 2004 30,935 ND 320, 363, 523 (203, 160, 160), 904 (203,
160, 146, 192, 203), 890 (203, 146,
146, 192, 203)
60 T141, S174, S205
06Cd-130 A B, Manitoba, Canada, 2006, 6
cases
30,803 ND 523 (203, 160, 160), 904 (203, 160, 146,
192, 203), 890 (203, 146, 146, 192,
203)
77 T141, S174, S205
CM-26 A B, Manitoba, Canada, 2000, 44
cases
30,901 ND 523 (203, 160, 160), 904 (203, 160, 146,
192, 203), 890 (203, 146, 146, 192,
203)
73 ND
M23257 Toxinotype 12, Quebec, Canada, 2004 ND ND 523 (203, 160, 160), 904 (203, 160, 146,
192, 203), 890 (203, 146, 146, 192,
203)
72 ND
a Calculated from the translated DNA sequence by using Protparam (http://ca.expasy.org/tools/protparam.html).
b Measured by infusion into a QTOF2 mass spectrometer, as described in Materials and Methods. In many cases, insufficient flagellin was isolated for accurate mass
measurements.
c Determined from bottom-up examination of flagellin glycopeptides. The bold number indicates the conserved 203-Da mass.
d Indicates the peptide sequences determined from MS/MS of FliC tryptic digests.
e Sites of glycan attachment, determined by electron transfer dissociation MS of FliC tryptic peptides.
f ND, not determined.
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skimmer region of the MS (nano-electrospray ionization–front-end collision-
induced dissociation MS/MS).
Solution enzymatic digests. To identify the type and location of glycosylation
sites, flagellin (50 to 200 g) or S-layer was digested with trypsin (Promega,
Madison, WI) at a ratio of 30:1 (protein/enzyme, vol/vol) in 50 mM ammonium
bicarbonate at 37°C overnight, as described previously (32). Protein digests were
analyzed by nano-liquid chromatography MS/MS (nLC-MS/MS) using either a
Q-TOF Ultima hybrid quadrupole time of flight MS (Waters, Milford, MA) (32)
or an LTQ XL linear ion trap MS (Thermo Fisher Scientific, Ottawa, ON,
Canada) coupled to a nanoAcuity ultrahigh-pressure liquid chromatography
system (Waters, Milford, MA). MS/MS spectra were acquired automatically on
doubly, triply, and quadruply charged ions.
HPLC purification of tryptic peptides. Tryptic digests of flagellin were frac-
tionated using an Agilent 1100 series high-pressure liquid chromatograph
(HPLC) with a diode array detector (Agilent Technologies, Palo Alto, CA). One
hundred microliters of each tryptic digest was separated using a 4.6- by 250-mm
Jupiter C18 reverse-phase column with a Phenomenex precolumn (Security-
Guard, Torrance, CA). Peptides were separated using a linear gradient of 5 to
60% acetonitrile and 0.5% formic acid over 40 min at a flow rate of 1 ml min1.
A 7-l aliquot of each fraction was retained, and the remainder was immediately
evaporated to dryness and stored at 20°C. Aliquots of each fraction were
screened by nLC-MS/MS using the QTOF2 to confirm the peptide contents of
each HPLC fraction.
Determination of glycan linkage sites by ETD. Electron transfer dissociation
(ETD) preserves delicate modifications during the fragmentation process and is
ideal for identifying the linkage sites of O-glycans (8, 27). Glycopeptide-contain-
ing HPLC fractions were infused at 1 l min1 into the electrospray ionization
source of an LTQ XL linear ion trap MS (Thermo Fisher Scientific, Ottawa, ON,
Canada) capable of performing ETD. Initially, collision-activated dissociation
MS/MS analysis was performed on the glycopeptide ions to confirm their iden-
tity. ETD was then performed using fluoranthene as the anionic reagent and with
supplementary activation enabled. The ETD reaction time was adjusted for
optimal fragmentation of each glycopeptide (35 ms).
Accurate mass determination of the glycan oxonium ion and glycan-related
fragment ions. Glycopeptide-containing HPLC fractions were infused at 1 l
min1 into the electrospray ionization source of an LTQ XL Orbitrap MS
(Thermo Fisher Scientific, Waltham, MA) and the MS/MS spectrum recorded
over a period of 20 min. Accurate mass determination of the glycan oxonium and
glycan-related fragment ions was achieved using a number of neighboring pep-
tide fragment ions as internal mass standards. Resolution was typically 50,000
(50% valley definition). Collision-induced dissociation MS/MS analysis was per-
formed on the glycopeptide ions to confirm their identity.
Sequencing of fliC genes from clinical isolates. fliC from each clinical isolate
was amplified by PCR from chromosomal DNA by using specific primers fliC 1F
(ATGAGAGTTAATACAAATGTAAGTGCTTTGATAGC) and fliC 1R (CT
ATCCTAATAATTGTAAAACTCCTTGTGGTTG). PCR products were
cloned into pCR2.1 (Invitrogen) and sequenced using both forward and reverse
sequencing primers by using BigDye Terminator v1.1 chemistry (Applied Bio-
sytems, Foster City, CA). Sequencing reactions were run on a 3100 genetic
analyzer from Applied Biosystems (Foster City, CA).
Inactivation of fliC and CD0240 genes in C. difficile 630 by using intron
retargeting. Target sites were identified for each gene by using the TargeTron
gene knockout system kit (Sigma Aldrich) and mutants generated according to
the method of Heap et al. (12). Briefly, one-tube splicing by overlap extension
PCR was used to assemble and amplify the PCR products containing the mod-
ified sequences for intron targeting to either the fliC gene or the CD0240 gene.
The fragments were cloned directly into pMTL007, and the targeted intron was
named to indicate the site of insertion within the gene (base number) and
orientation (sense [s] or antisense [a]). The plasmids were pMTL007:Cdf-fliC-
260a and pMTL007:Cdf-240-864s. Each of the modified plasmids was transferred
from Escherichia coli CA434 into C. difficile 630erm (12) by conjugation, and
transformants were selected on BHI plates containing 250 g ml1 cycloserine
and 15 g ml1 thiamphenicol to select for C. difficile containing the retargeted
plasmid integrants. Single thiamphenicol-resistant colonies were resuspended in
phosphate-buffered saline and plated at an appropriate dilution on BHI plates
containing 2.5 g ml1 erythromycin (Erm) to select for the presence of a spliced
erythromycin retrotransposition-activated selectable marker which indicates in-
tron integration. Erm-resistant colonies were examined by PCR using flanking
primers for each gene (see Table S1 in the supplemental material) with the EBS
universal primer (CGAAATTAGAAACTTGCGTTCAGTAAAC) to confirm
integration into each gene of interest. In addition, PCRs with Erm-specific
primers were used to confirm splicing of the retrotransposition-activated select-
able marker.
Electron microscopy. Copper grids (Electron Microscopy Sciences, Fort
Washington, PA) were covered with Formvar film and coated with carbon. For
sample preparation, grids were floated on a drop of bacterial cells for 5 min.
After being blotted dry, the grids were negatively stained with ammonium mo-
lybdate (1%, wt/vol). Images were taken with a Zeiss EM902 transmission elec-
tron microscope operated at an accelerating voltage of 80 kV.
PCR analysis of flagellar glycosylation islands. Chromosomal DNA was pre-
pared from clinical isolates by using the DNeasy blood and tissue kit (Qiagen
Inc., Mississauga, ON, Canada). Primers spanning regions of the glycosylation
island from QCD32g58 were used in reactions with chromosomal DNA and the
Qiagen long-range PCR kit to determine the genetic content of each strain. PCR
products were analyzed on agarose gel.
Nucleotide sequence accession numbers. The C. difficile fliC DNA sequences
have been deposited in GenBank under accession numbers GU048823 to
GU048830.
RESULTS
Motility of C. difficile isolates. Two recent comparative
genomic studies of C. difficile isolates indicated that flagellum
production and consequent motility may not be common fea-
tures due to an absence of flagellar structural genes from a
number of the genomes examined (14, 26). To determine if
motility could be assessed by traditional techniques, we first
examined the motility of clinical isolates by using motility agar
plates. Strains of C. difficile were examined by stab inoculation
onto standard motility agar plates (0.4% agar). In contrast to
Campylobacter jejuni, which exhibits a diffuse spreading phe-
notype on this type of agar, C. difficile strains failed to produce
the spreading pattern typical of other motile organisms (data
not shown). We examined the abilities of cells from both broth-
and agar-grown cultures in this manner, yet no obvious motility
was observed. We next examined C. difficile strains stab inoc-
ulated into motility agar tubes (0.175% agar) as described by
Tasteyre et al. (30). All C. difficile strains did display a spread-
ing diffuse growth away from the inoculum stab in this assay,
suggestive of a motile phenotype (Fig. 1). Only strain CM-26
appeared to be nonmotile by this assay.
SDS-PAGE analysis of flagellin proteins. Flagellin purified
from the cell surface of Clostridium difficile strains (listed in
Table 1) was analyzed by sodium dodecyl sulfate-polyacryl-
amide gel electrophoresis (SDS-PAGE) (Fig. 1). In each case,
a single predominant protein band was observed in gels, and it
migrated at approximately 33 to 36 kDa. Peptide MS/MS anal-
FIG. 1. Characterization of C. difficile isolates. The upper panel
shows motility stabs of clinical isolates (0.175% agar). Motility was
clearly visible in agar stabs for all strains with the exception of CM-26.
The lower panel depicts an SDS-PAGE gel of FliC protein extracts.
Lane 1, C. difficile 630; l ane 2, C. difficile BI-1; l ane 3, C. difficile BI-7;
l ane 4, C. difficile QCD32g58; l ane 5, C. difficile M23257; l ane 6, C.
difficile M46846; l ane 7, C. difficile M7465; l ane 8, C. difficile M9349;
l ane 9, CM- 26; l ane 10, CM- 56; l ane 11, 06CD130. Molecular
masses (in kDa) are shown to the left of the gel.
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ysis of the extracted gel band from each strain confirmed that
this major protein band was the product of the fliC gene for
each strain. Only the protein sample prepared from strain
QCD32g58 failed to contain any major protein species corre-
sponding to flagellin. However, a peptide MS/MS analysis of a
tryptic digest of a partially purified S-layer preparation from
this strain did identify three flagellin-specific peptides in the
sample (T39–50AADDAAGLAISE, T65–89NVQDGISVVQTA
EGALEETGNILQR, and T92–107TLSVQSSNETNTAEER),
indicating that this strain does produce flagellin protein, al-
though in much smaller amounts. Negative staining and exam-
ination of strain 630 and QCD32g58 cells by transmission elec-
tron microscopy revealed that filaments were present in
QCD32g58, although in greatly reduced amounts relative to
630 (Fig. 2A and B). It should be noted that, with tube motility
assays, this strain did exhibit a spreading, diffuse phenotype
typical of motility (Fig. 1). In a related fashion, when strain
CM-26 was tested in motility agar, it appeared nonmotile,
although when cells were grown for flagellin production, ex-
amination by SDS-PAGE demonstrated that flagellin protein
could be extracted from the surface of bacterial cells. Variabil-
ity of both the motility phenotype and flagellin production
among separate batch growths of some isolates is suggestive of
a phase-variable phenotype. Recent work described phase vari-
ation of another cell surface-associated protein, CwpV (9).
Genetic analysis of flagellin genes from Clostridium difficile
isolates. For C. difficile strains BI-1, BI-7, 06CD130, M9349,
M46846, M7465, CM-56, and CM-26, the fliC structural gene
was amplified from genomic DNA using PCR with flagellin-
specific primers. The resulting amplicons were cloned and se-
quenced, and the predicted amino acid sequence and mass of
each respective flagellin were determined from the DNA se-
quence data. With the exception of the flagellin sequence from
strains M46846 and CM-56, the amino acid sequences pre-
dicted from fliC genes from recent clinical isolates of C. difficile
were identical. All sequences were highly conserved, with only
four amino acid substitutions in the flagellin sequence from
strain M46846 and a single amino acid substitution in the
flagellin sequence of strain CM-56. The complete genome se-
quence of strain 630 as well as shotgun sequences of eight
other strains are now available through the NCBI and DOE
databases. The alignment of all FliC protein sequences (see
Fig. S1 in the supplemental material) demonstrated that the
flagellin genes of sequenced recent clinical isolates and the
clinical isolates used in this study were remarkably conserved,
with no more than seven amino acid substitutions. In contrast,
C. difficile strain 630 showed the lowest degree of flagellin
sequence conservation, with 29 amino acid substitutions com-
pared with the other sequences. These substitutions appeared
to reside mainly within the central variable region of the flagel-
lin primary sequence. As predicted due to functional con-
straints for subunit-subunit interaction and proper folding of
flagellin monomers, both the N- and C-terminal amino acid
sequences were conserved among all strains examined (22).
Intact mass analysis of C. difficile flagellins. The observed
masses of flagellin proteins from C. difficile strains 630, BI-1,
M7465, and M9349 were obtained by infusion into a QTOF2
MS (Table 1). The protein mass spectrum of flagellin from
each strain showed an envelope of multiply charged protein
ions from which the reconstructed molecular mass profile was
calculated. None of the intact masses measured matched pre-
cisely the mass predicted from the translated gene sequence,
suggesting that these flagellins were posttranslationally modi-
fied. In the case of strain 630, the reconstructed molecular
mass profile showed two major peaks at 33,559 and 33,160 Da
(Fig. 3A), significantly greater than the predicted protein mass
of 30,755 Da. Of significance, the observed major intact mass
peaks were separated by a mass of 398 Da (see below).
Comparison of the observed protein intact mass of C. difficile
630 suggests that it corresponds to the flagellin protein FliC,
bearing six or seven residues modified with a glycan of 398 Da.
The reconstructed molecular mass profile of strain BI-1
showed a more complex spectrum, with major intact mass
peaks at 35,106, 35,473, and 35,841 Da. Minor peaks were
clearly visible at 36,208 and 37,166 Da (Fig. 3B). All masses
were greater than the mass predicted from the translated gene
sequence (30,901 Da). The reconstructed molecular mass pro-
files of C. difficile strains M9349 and M7465 also showed a
more complex intact molecular mass profile, which closely re-
sembled that of BI-1, with intact masses listed in Table 1.
Top-down analyses of C. difficile flagellins. Previously, we
have shown that examination of intact flagellar proteins by elec-
trospray ionization MS allows the identification of labile-glyco-
protein-associated ions, in particular, glycan-related ions (24). We
used this technique to examine the posttranslational modifica-
tions of C. difficile flagellins in this study (Fig. 3C and D).
MS/MS analyses of multiply charged protein ion precursors
of FliC from strain 630 showed an abundant ion at m/z 399.1
FIG. 2. Electron microscopy of uranyl acetate-stained cells. (A) C. difficile 630. (B) C. difficile QCD32g58. (C) C. difficile 630::0240 erm. (D) C.
difficile 630::fliC erm.
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(Fig. 3C). Increasing the voltage of RF lens 1 promoted the
formation of labile-protein-associated fragments ions in the
orifice/skimmer region of the MS, allowing MS/MS spectra of
the ions to be recorded. Second-generation MS/MS spectra
were recorded for the ion at m/z 399.1, which gave dominant
fragment ions at m/z 284.1, 214.1, 186.1, and 116.1. No frag-
ment ions corresponding to peptide type y or b ions were
observed, suggesting that the observed fragment ions were
more typical of those observed for glycan fragmentation.
In contrast to C. difficile 630 flagellin (FliC), a similar
MS/MS analysis of a multiply charged protein ion of FliC from
C. difficile strain BI-1 showed an intense ion at m/z 204.1,
which would typically correspond to a N-acetyl hexosamine
(HexNAc) residue (Fig. 3D). No evidence for a glycan oxo-
nium ion at m/z 399 was observed for this flagellin sample.
Other ions, of weaker intensity, were observed at m/z 161.1,
364.1, and 524.1. As with C. difficile 630 FliC, no ions charac-
teristic of peptide b or y ions were observed, suggesting that the
ion observed at m/z 524.1 was a glycan ion. Also observed in
this region were fragment ions at m/z values of 186.1, 168.1,
and 138.1, characteristic of HexNAc sugar fragmentation. Of
significance, neutral losses of 160 Da were observed from the
precursor ion, suggesting that the ion observed at m/z 161.1 is
glycan related. From this initial analysis, it is apparent that the
glycan present on flagellin from C. difficile BI-1 is quite distinct
from that found on C. difficile 630. Similar second-generation
ion spectra were recorded for multiply charged protein ions
from C. difficile strains M9349 and M7465, with product ion
spectra similar to those observed for MS/MS of multiply
charged protein ions from strain BI-1 (data not shown).
nLC-MS/MS analysis of C. difficile flagellin peptide digests.
Preliminary data were collected by analysis of the tryptic digest
of the C. difficile 630 FliC by nLC-MS/MS. Many of the MS/MS
spectra could be readily assigned to unmodified flagellin tryptic
peptides. A number of spectra, however, were derived from
peptides that appeared to possess a glycan modification. Figure
4A shows the peptide MS/MS spectrum of the tryptic glyco-
peptide T176–189IQLVNTASIMASAGITTASIGSMK. Peptide
type y and b fragment ions were observed at very low intensi-
ties, with the spectrum dominated by a glycan oxonium ion at
m/z 399.1. The total mass of the glycopeptide was 3,160.24 Da
(predicted peptide mass, 2,364.26 Da), which suggested mod-
ifications with two glycans of 398 Da. This glycan was also
found on three other glycopeptides (T135–144LLDGTSSTIR,
T202–212TMVSSLDAALK, and T191-201AGGTTGTDAAK).
In contrast to the case for C. difficile 630 FliC, bottom-up
analysis of FliC from BI-1 revealed a distinct pattern of glyco-
sylation. Figure 4B shows the MS/MS spectrum of the modified
tryptic peptide from BI-1 FliC, T135-144LLDGSSTEIR. A num-
ber of modified tryptic peptides were detected (T145-166LQV
GANFGTNVAGTTNNNNEIK, T167-178VALVNTSSIMSK,
T202-212QMVSSLDVALK, and T124-134ISSSIEFNGKK), all
with what appeared to be a 523-Da modification, composed of
residue masses of 160, 160, and 203 Da. Neutral losses of 160,
160, and 203 Da were observed in the high-m/z region of the
spectrum. Weak fragment ions at m/z 204.1 and 161.1 were also
observed. It was possible to infer the peptide sequence from
the peptide y ion sequence. In an attempt to increase the
sequence coverage, flagellin tryptic peptides from strain BI-1
were separated by HPLC. MS/MS analyses of the HPLC frac-
FIG. 3. Electrospray MS analyses of intact flagellin from strains of
C. difficile. (A) The reconstructed molecular mass profile of FliC from
C. difficile 630, showing two peaks at 33,559 and 33,160 Da. These are
2,804 and 2,405 Da larger than that predicted from the translated gene
sequence of fliC and correspond to the attachments of six and seven
glycan moieties of 398 Da. No signal corresponding to the unmodified
flagellin was observed. (B) The reconstructed molecular mass profile
of FliC from C. difficile BI-1, showing intense peaks at 35,106, 35,473,
and 35,841 Da and less intense peaks at 36,208 and 37,186 Da, all
larger than the mass of FliC, which was predicted to be 30,901 Da.
(C) Tandem MS analysis of the multiply charged protein ion from C.
difficile strain 630 at m/z 1,119.730. Intense ions were observed at m/z
399.1, the putative glycan observed to modify FliC from this strain, and
glycan-associated fragment ions were observed at m/z 284.1, 214.1, and
116.1 (indicated by an asterisk). (D) MS/MS analysis of the multiply
charged protein ion from C. difficile BI-1 m/z 1,140.731. Numerous
ions were observed in the resulting MS/MS spectrum, including glycan-
associated ions at m/z 524.1, 364.1, 204.1, and 161.1. MS/MS spectra
were acquired at collision energy of 15 to 35 V by using argon as the
collision gas.
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tions showed glycopeptides with identical amino acid sequence
but variable glycan modifications. For example, the tryptic
glycopeptide T135-144LLDGESTEIR was observed to be mod-
ified with a glycan of 523 Da, 904 Da, or 840 Da. Significantly,
each glycopeptide eluted at distinct retention times, indicating
that these are distinct glycan modifications rather than exper-
imental artifacts generated by in-source MS fragmentation.
There appeared to be no pattern in site occupancy, with each
FIG. 4. MS analysis of modified tryptic peptides from flagellar proteins of C. difficile strains 630 and BI-1. (A) nLC-MS/MS spectrum of the doubly
protonated T167–190 glycopeptide ion at 1,581.82 from C. difficile 630. The spectrum is dominated in the high-molecular-m/z region by the sequential loss
of two carbohydrate moieties. Two sequential losses of m/z 199.12 corresponds to the loss of a doubly charged glycan of a residue mass of 398.1 Da
(indicated by the arrow). The low-m/z region of the spectrum is dominated by the carbohydrate oxonium ion (m/z 399.1) and what could be a
fragmentation component (m/z 214.1). (B) nLC-MS/MS spectrum of the doubly protonated T135–144 glycopeptide ion 807.42 from C. difficile BI-1. The
high-m/z region is dominated by the sequential loss of m/z 160.1, 160.1, and 203.1 from what appears to be a trisaccharide. Oxonium ions are visible at
m/z 204.1 (HexNAc) and m/z 161.1. The glycan appears to be O linked through the HexNAc residue.
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glycopeptide observed to be modified with the 523-Da, 904-Da,
or 840-Da glycan. A similar pattern of glycan modification was
observed for flagellins of other clinical C. difficile isolates.
These are summarized in Table 1.
Glycopeptides were characterized from clinical strains from
both Quebec and Manitoba, Canada, and shown to contain
glycan structures closely resembling those found on BI-1 flagel-
lin. Glycopeptide MS/MS spectra from BI-1 also showed a
series of neutral losses of 203, 160, and 146 Da from the
modified glycopeptide ion. In BI-1, BI-7, and the Canadian
clinical isolates, MS fragmentation of glycopeptides revealed
that HexNAc was the linking sugar connecting to the protein
backbone (203.1 Da) with a oligosaccharide chain composed of
putative deoxyhexoses (146 Da) or methylated deoxyhexoses
(160 Da) and a monosaccharide of 192 Da (putative heptose).
These were present in various combinations to form glycans of
unique chain lengths (Table 1).
Determination of glycan attachment sites by ETD. Analysis
of the sequence of glycopeptides did not reveal any N-linked
sequons; therefore, the modification was thought to be O
linked. ETD preserves delicate modifications during the frag-
mentation process and is ideal for identifying the linkage sites
of O-linked glycans (8, 13). Glycopeptide-containing HPLC
fractions of C. difficile 630 flagellin digest were infused into the
electrospray ionization source of an LTQ XL linear ion trap
capable of performing ETD. Initially, collision-activated disso-
ciation MS/MS analysis was performed on the glycopeptide
ions to confirm their identity. ETD was performed using flu-
oranthene as the anionic reagent and with supplementary ac-
tivation enabled. The ETD reaction time was adjusted for
optimal fragmentation of each glycopeptide. Five of the seven
sites of glycosylation were identified in this manner for C.
difficile 630 FliC as S141, S174, T183, S188, and S205, and three of
these sites were confirmed as sites of glycosylation in seven
additional strains (Table 1). It appears that the O-linked sites
of glycosylation are conserved among strains and are localized
to the central variable region of the FliC protein, which forms
the surface-exposed D2 and D3 domains within the folded
monomer.
Structural characterization of unusual O-linked glycan moi-
eties by MS/MS analyses. One of the challenges in structural
elucidation of novel bacterial glycans is the relatively poor
sensitivity of nuclear magnetic resonance, which requires mil-
ligram quantities of purified material. Due to the relatively low
abundance of this protein on the cell surface, we have not been
able to obtain a sufficient quantity of glycan for detailed struc-
tural analysis. However, high-resolution MS can provide a con-
siderable amount of information on glycan structure and com-
position. Fragmentation patterns of glycans attached to
protein can provide information on the organization of the
glycan structure as well as identify the linking sugar moiety.
Further inspection of the m/z 399.1 glycan oxonium ion
MS/MS spectrum from a C. difficile 630 flagellin glycopeptide
yielded information regarding the glycan composition. Loss of
115 Da from the parent ion yielded a fragment ion at m/z 284.1,
and neutral loss of 98 Da from this ion produced an ion of m/z
186.1. The loss of 98 Da could plausibly be assigned to phos-
phoric acid, yielding a dehydrated HexNAc (m/z 186.1) (Fig.
5A). Furthermore, loss of dehydrated HexNAc (185 Da) from
the m/z 399.1 parent ion gave rise to an intense fragment ion at
m/z 214.1 (Fig. 5A). Further MS/MS spectra of the glycan-
associated fragment ions were collected. Triple MS of m/z
284.1 showed a loss of phosphoric acid (98 Da), to give a
fragment ion at m/z 186.1 (Fig. 5B). Triple MS of a glycan
fragment ion at m/z 214.1 showed a neutral loss of 98 Da
(phosphoric acid) and a strong ion at m/z 116.1 (Fig. 5C).
Where possible, accurate mass measurements were per-
formed for the glycan-related fragment ions in glycopeptide
MS/MS spectra, and these were used to determine plausible
elemental formulae of unknown glycans. The accurate masses
and top-ranked plausible elemental compositions are shown in
Table 2. The top-ranked elemental formula of the ion of m/z
186.1 indicated this to be a dehydrated HexNAc. This was
further confirmed by the presence of a weak ion at m/z 204.1 in
several glycopeptide MS/MS spectra and characteristic
HexNAc-associated fragment ions (m/z 168.1 and 138.1 [15]).
The top-ranked elemental formula of the glycan-associated
fragment ions at m/z 214.1 and 284.1 supported our suggestion
of a phosphate linkage within the sugar. The elemental for-
mula of the unknown fragment ion of m/z 116.1 suggested a
methylated aspartic acid. The quadruple MS fragmentation of
m/z 116.1 supported this, with fragment ions characteristic of
an aspartic acid immonium ion (m/z 88.1) and amino acid
backbone (m/z 57) (data not shown). The 398-Da flagellar
glycan is likely to be a HexNAc linked to methylated aspartic
acid via a phosphate linkage. The glycan is linked to the pro-
tein via the HexNAc moiety.
Flagellins from C. difficile strains BI-1 and BI-7 and the
Canadian clinical isolates were found to be modified with sev-
eral novel glycan moieties, ranging in mass from 494 Da to 917
Da (Table 1). The complex oligosaccharides are composed of
various components, which were identified by their character-
istic neutral losses and corresponding glycan oxonium ions.
Plausible candidates, based upon residue mass for each resi-
due, are HexNAc (203 Da), deoxyhexose (146 Da), and hep-
tose (192 Da). Accurate mass measurements where glycan-
related ions were observed in peptide MS/MS spectra, were
performed. From these measurements, plausible elemental
formulae were calculated for the 523-Da glycan and the m/z
204.1 and 161.1 glycan-related ions. The top-ranked elemental
formula for m/z 204.1 glycan fragment ion was consistent with
HexNAc, while the top-ranked elemental formula for m/z
161.1 fragment ion was consistent with a methylated deoxyhex-
ose (Table 2).
Bioinformatic analysis of C. difficile flagellar glycosylation
locus. The genome of C. difficile 630 was recently published
FIG. 5. Analysis of the unusual carbohydrates obtained by nano-electrospray ionization–front-end collision-induced dissociation MS/MS.
(A) MS/MS spectra of the oxonium ion at m/z 399.1. Intense fragment ions were observed at m/z 284.1 and 214.1, with weaker ions at m/z 204.1
and 116.1. (B) MS/MS spectrum of glycan fragment ion at m/z 284.1. Neutral loss of 98 Da from the parent ion resulted in a fragment ion at m/z
186.1. (C) MS/MS spectrum of glycan fragment ion at m/z 214.1. A neutral loss of 98 Da resulted in an observed fragment ion at m/z 116.1.
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(25), and seven additional shotgun sequences of highly virulent
C. difficile isolates from Quebec, Newfoundland, and Ontario,
Canada, Minneapolis, MN, and Marne, France, are available
through the DOE Joint Genome Institute integrated database
(http://img.jgi.doe.gov). A preliminary BLAST analysis of the
flagellin genetic locus revealed that glycan biosynthesis genes
were present in all genomes in close proximity to the flagellar
structural gene fliC. Bioinformatic analysis of the genes lying
FIG. 6. Schematic diagram showing the genetic organization of the flagellar glycosylation locus in C. difficile strains. The diagram shows the region of the
chromosome flanked by the fliC and flgB structural genes, which encode flagellin (FliC) and FlgB (rod protein), respectively. Flagellar structural genes fliC and
flgB are colored black; for the flagellar glycosylation locus genes, glycosyltransferase genes are dark gray and precursor glycan biosynthesis genes are light gray.
In theC. difficile 630 locus, the genes annotated as a phosphatase gene (CD0241), sugar nucleotide transferase gene (CD0242), and hypothetical ORF (CD0243)
are colored light grey. The available shotgun sequence data for strain QCD32g58 (orf2/GT2 and orf3/GT3) and for CIP107932 (orf1/GT1) likely contain
sequencing errors, which result in truncation of the respective ORF. The schematic displays the full-length ORF for each of these genes.
TABLE 2. Accurate masses of the glycan oxonium and glycan-related fragment ions and most plausible empirical formulaa
Carbohydrate
fragment ion Strain
Mean accurate
m/z  SD
Residue mass
(Da)
Elemental
composition
Predicted
oxonium ion
(m/z)
399.1 630 399.1164 0.0012 398.1086 C13H24N2O10P 399.1163
284.1 630 284.0536 0.0010 284.0458 C8H15NPO8 284.0530
214.1 630 214.0481 0.0072 213.0403 C5H13NO6P 214.0475
204.1 630 204.0865 0.0004 203.0787 C8H14NO5 204.0867
186.1 630 186.0766 0.0007 185.0688 C8H12NO4 186.0761
116.1 630 116.0706 0.0003 115.0628 C5H10NO2 116.0706
524.2 BI-1 524.2311 0.0049 523.2231 C22H38NO13 524.2338
204.1 BI-1 204.0864 0.0059 203.0745 C8H14NO5 204.0866
161.1 BI-1 161.0811 0.0072 160.079 C7H13O4 161.0808
a For C. difficile strain 630, fragment ions y3 (m/z 389.2513), y2 (m/z 288.2036), and y8 (m/z 836.4114) from the peptide T135-144LLDGTSSTIR were used as references.
Hydrogen mass, 1.0078 Da. For C. difficile strain BI-1, fragment ions y3 (m/z 417.2462), y2 (m/z 288.2036), and y8 (m/z 807.335) from the peptide T135-144LLDGSSTEIR
glycopeptide ion 807.42 were used.
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immediately downstream in C. difficile 630 indicated that be-
tween the fliC structural gene and flgB structural gene lies a
putative flagellar glycan biosynthesis locus (CD0241 to
CD0244). In the clinical isolates, this locus showed consider-
able genetic diversity and increased size compared to that of C.
difficile 630 (Fig. 6). C. difficile 630 has the least complex com-
plement of carbohydrate biosynthesis genes in this region. Im-
mediately downstream of fliC is a putative glycosyltransferase
gene (CD0240). In addition, four other genes, namely,
CD0241, CD0242, CD0243, and CD0244, are present and ap-
pear to encode a putative phosphatase, a sugar nucleotide
(nucleoside triphosphate) transferase, a hypothetical open
reading frame (ORF), and a second glycosyltransferase, re-
spectively, based on Blastp analysis (Table 3).
In contrast, the corresponding genetic locus in the seven
shotgun-sequenced isolates is much larger and is highly con-
served in genetic content (Fig. 6). Each strain has three ORFs
lying immediately downstream of the fliC gene which are tran-
scribed in the same orientation and which encode glycosyl-
transferases (GT1, GT2, and GT3). For C. difficile strain CIP
107932, the GT1 gene is annotated as two separate ORFs, and
for C. difficile QCD32g58, the GT2 and GT3 genes are anno-
tated as two separate ORFs, although the overall sequence is
highly conserved among all strains (90% identity) and it is
likely that each GT is a single continuous ORF. The annota-
tion of each GT into two ORFs is likely due to sequencing
errors in these shotgun sequences. The GT2 ORF appears to
encode a bifunctional protein which contains a GT2 family
domain (PFAM 00535), as well as a methyltransferase domain
(PFAM 08241). In addition to containing the three conserved
GT ORFs, this extended locus also contains a number of ORFs
encoding proteins with predicted enzymatic functions of rele-
vance to glycan biosynthesis pathways. These include proteins
with homology to a dehydrogenase, deaminase, aminotransfer-
ase, and isomerase enzyme (Table 3). A hypothetical protein
with homologs in a number of bacterial species was also
present in all virulent strains examined. While the genetic
content of this locus is conserved, it is quite distinct from that
found in the C. difficile 630 genome. However, a homolog of
CD0240 (with 80% identity) which lies proximal to the fliC
structural gene is present in all strains (GT1). PCR analysis
using primers specific to genes of this glycosylation island with
chromosomal DNA from each clinical isolate characterized in
this study confirmed the presence of a homolog of the GT1/
CD0240 gene in each of these strains. In addition, appropriate-
sized PCR fragments were obtained when primers spanning
the genes of the extended glycosylation island were used, dem-
onstrating the conservation of this extended locus among the
recent Canadian clinical isolates (data not shown).
Characterization of fliC and CD0240 mutant strains of C.
difficile. To further understand the contribution of the flagellin
protein to motility of C. difficile cells and to characterize the
flagellar glycosylation pathway, we next generated insertionally
inactivated fliC and CD0240 mutants by using the recently
published ClosTron targeted mutagenesis approach (12). In-
sertion of the TargeTron Erm resistance marker into either
fliC or CD0240 was confirmed by PCR using primers flanking
the gene of interest and with primers specific to the TargeTron
Erm resistance marker (data not shown). The mutant strains
were grown overnight, and flagellin protein extracts prepared
as described above were analyzed by SDS-PAGE. As can be
seen in Fig. 7, production of flagellin protein in the fliC mutant
was completely abolished in contrast to that of the parent (lane
3). In contrast, analysis of the flagellin extract from the C.
TABLE 3. Flagellar glycosylation locus genes and similarity of predicted proteins to proteins in the microbial genome database
Strain and gene Predicted function(s) (E value) C. difficile homolog(s)
630
CD0240 (GT1) -(1,4)-Glycosyltransferase (6e29), ExoA homolog (2e12), GT family 2 (5e10) CIP 107932, 23m63, 32g58, 37x79,
63q42, 76w55, 97b34,
CD0241 Phosphoserine-phosphatase-like protein (2e17) None
CD0242 Phosphocholine cytidylyltransferase (1e21) None
CD0243 Methyltransferase (2e27) None
CD0244 CDP-glycerol:poly(glycerophosphate) glycerophosphotransferase (1e18),
cholinephosphotransferase (3e7), GT family 2 (3e6)
None
QCD32g58
orf1 (GT1) GT family 2 (2e57) 37x79, 63q42, 97b34, CIP 107932,
23m63,76w55
orf2 (GT2) GT family 2 (3e38), methyltransferase (2e13) 37x79, 63q42, 97b34, CIP 107932,
23m63,76w55
orf3 (GT3)a GT family 2 (9e73), streptomycin biosynthesis protein (4e47) QCD32g58, 63q42, 97b34, CIP
107932, 23m63,76w55
orf4 Carbamoyl-phosphate synthase large subunit (6e38), biotin carboxylase (1e20) 37x79, 63q42, 97b34, CIP 107932,
23m63,76w55
orf5 Ornithine cyclodeaminase (2e74) 37x79, 63q42, 97b34, CIP 107932,
23m63,76w55
orf6 FdtA, dTDP-4-keto-6-deoxy-D-glucose-3,4-ketoisomerase (2e29) 37x79, 63q42, 97b34, CIP 107932,
23m63,76w55
orf7 TDP-3-aminoquinovose aldamine (2e101), glutamine-scyllo-inositol transaminase
(4e133)
37x79, 63q42, 97b34, CIP 107932,
76w55
orf8 3-Amino-5-hydroxybenzoic acid synthase family (5e119), aminotransferase family (1e9) 37x79, 63q42, 97b34, CIP 107932,
76w55
a orf3 protein sequence from C. difficile 37x39 used in Blastp, as potential sequencing errors in QCD32g58 gene cause a truncation in the ORF.
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difficile 630::0240erm strain revealed a minor amount of a pro-
tein of a molecular mass corresponding to unmodified flagellin
(Fig. 7A, lane 2). The ability to glycosylate the flagellin protein
appears to be required for optimal production at the cell sur-
face. We extracted this band from the gel, and peptide MS/MS
analysis confirmed that this protein was the product of the fliC
gene. In addition, the majority of the peptides in the tryptic
digest were readily identified by nLC-MS/MS, giving 62% se-
quence coverage. Tryptic peptides that had previously been
observed to harbor the 398-Da glycan modification were ob-
served to be unmodified on flagellin prepared from the C.
difficile 630::0240erm strain. For example, the peptide T202–212
TMVSSLDAAK was observed as a doubly charged ion at m/z
730.8 in C. difficile 630. The same peptide was identified from
the C. difficile 630::0240erm mutant as a doubly charged ion, at
m/z 532.3, corresponding to the predicted mass of the unmod-
ified peptide. The MS/MS spectrum of this peptide showed a
clear sequence of peptide type y and b ions, corresponding to
the amino acid sequence T202–212TMVSSLDAALK. Notably,
there were no glycan-associated ions observed in the low-mass
region of the MS/MS spectrum, confirming that this peptide
was unmodified in the absence of the glycosyltransferase (data
not shown). Glycosylation appears to be required for optimal
flagellin protein production, as the amounts produced by C.
difficile 630::0240erm were much reduced, as evidenced by
SDS-PAGE analysis. Negative staining of bacterial cells and
examination by electron microscopy revealed that, as expected,
no flagellar filaments were produced in the fliC mutant strain
(Fig. 2D). In contrast, negative staining of C. difficile
630::0240erm cells revealed that flagellar filaments were pro-
duced but only in limited amounts compared to those of the
parent strain, and these filaments appeared to be truncated in
length (Fig. 2, compare panels A and C).
Motility screening of fliC and CD0240 mutant strains. Each
strain was grown overnight on supplemented BHI agar con-
taining Erm. A loopful of cells were used to stab inoculate
motility agar tubes as described above. The C. difficile
630::fliCerm and C. difficile 630::0240erm strains no longer
displayed a spreading phenotype in this motility agar, in con-
trast to the parent strain (Fig. 7B).
DISCUSSION
We demonstrate in this study that the flagellin proteins pro-
duced by C. difficile are glycoproteins with unique modifica-
tions. C. difficile 630 produces flagellin, which is glycosylated in
O linkage at up to seven sites with a HexNAc residue, to which
a methylated aspartic acid is linked via a phosphate bond. In
contrast, flagellins from a number of C. difficile isolates from
more recent outbreaks are modified in O linkage with a het-
erogeneous glycan containing up to five monosaccharide resi-
dues with masses of 204 (HexNAc), 146 (deoxyhexose), 160
(methylated deoxyhexose), and 192 (heptose). The composi-
tions of the C. difficile glycans are quite distinct from that
observed recently for flagellin from the related organism C.
botulinum. The flagellar glycans characterized from C. botuli-
num isolates were shown to be either derivatives of the novel
prokaryotic nonulosonate sugars or di-N-acetylhexuronic acids
(7, 32, 33).
All C. difficile flagellins examined were shown to produce a
glycan which is attached to serine and threonine residues in the
protein sequence via a linking HexNAc monosaccharide. This
observation suggested that the glycan biosynthesis assembly
machinery in C. difficile is likely to be conserved, at least in
part, among all strains. To explore this possibility, bioinfor-
matic analysis of all C. difficile genomes identified a homolog of
a gene in C. difficile 630 (CD0240) which encodes a glycosyl-
transferase enzyme. This gene lies immediately downstream of
the fliC gene in all strains. In this study, we show that inacti-
vation of CD0240 gene by using the ClosTron mutagenesis
system results in cells which are no longer motile and can
produce only limited amounts of unglycosylated flagellin. It
remains to be determined if the product of the CD0240 gene is
responsible for the transfer of only the initial HexNAc sugar to
the flagellin protein or for the addition of the complete glycan,
FIG. 7. Characterization of C. difficile mutants. (A) SDS-PAGE
analysis of flagellin extracts of C. difficile 630 (lane 1), C. difficile
630::0240erm (lane 2), and C. difficile 630::fliCerm (lane 3). Molecular
masses (in kDa) are shown to the left of the gel. Asterisk, protein of a
molecular mass corresponding to unmodified flagellin. (B) Motility
stabs (0.175% agar) show C. difficile 630 (lane 1), C. difficile
630::0240erm (lane 2), and C. difficile 630::fliCerm (lane 3).
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but from this study, we show that the enzyme activity is re-
quired for glycosylation to occur. We also show that glycosy-
lation of the flagellin protein is required for proper assembly
and consequent motility.
This process of flagellar glycosylation has also been shown to
be required for motility in a number of other bacterial patho-
gens, including Campylobacter jejuni, Helicobacter pylori, and
Aeromonas caviae, which are all known to colonize the gastro-
intestinal tract. In contrast, O-linked flagellar glycosylation,
which occurs in Pseudomonas aeruginosa, Pseudomonas syrin-
gae, and Listeria monocytogenes, is not required for flagellar
assembly, although in the case of P. aeruginosa and P. syringae
pv. tabaci 6605, the glycan has been implicated in virulence (2,
28). The current study provides the first example of a gram-
positive anaerobe in which the glycosylation process is required
for flagellar assembly. While the flagellin of Clostridium botu-
linum was shown to be glycosylated, the role of the glycosyla-
tion process in assembly and motility had not been investi-
gated. With the recent development of mutagenesis tools for
clostridial species, it will now be possible to determine if the
glycosylation process is also required for flagellar assembly in
C. botulinum. The precise biological role of the glycosylation
process in flagellar assembly has yet to be determined. It may
be required for stability of subunit-subunit interactions within
the flagellar filament or alternatively required for efficient se-
cretion of the flagellin monomer through the basal body ap-
paratus.
As the flagellar glycans from the clinical isolates are quite
distinct in structure from that made by C. difficile 630 and there
appears to be conservation in the genetic content of this locus
among the seven recent genome-sequenced isolates as well as
the clinical isolates examined in the current study, it is possible
that the glycan may also contribute to the pathogenic potential
of these strains. Future work will be directed toward defining
whether motility or the glycans play a role in colonization and
in determining if there is a correlation between glycan struc-
ture and virulence of isolates.
It is important to acknowledge that two recent genomic mi-
croarray studies suggest that motility may not be required for
virulence due to divergence in content of flagellar coding se-
quences among strains (14, 26). However, in the study by Stabler
et al. (26), the group of genes comprising the flagellar glycosyla-
tion locus from QCD32g58 were not included in the microarray.
In the study by Janvilisri et al. (14), primers of approximately 70
bp specific for each of the flagellar glycosylation island genes from
the QCD32g58 locus were included in the microarray, in addition
to primers specific for CD0240 from C. difficile 630. Of the 35
human strains tested by microarray, only 3 strains were missing a
single gene from this locus, while 2 strains appeared to be missing
three of the genes (Yung-Fu Chang, personal communication),
supporting the observation in the current study that this locus is
conserved among human isolates. In contrast to the results ob-
tained by microarray, for which it appears that the CD0240 gene
is divergent or absent in a significant number of isolates, we show
by PCR that a homolog of CD0240 is present in all genome-
sequenced isolates as well as in clinical isolates in the current
study. It should be noted that sequence diversity in the region of
this gene which spans one of the primers used in the microarray
may be responsible for the results obtained in the analysis of
Janvilisri et al. (14), which indicated that the gene was divergent
or absent in many isolates.
While motility may not be an essential virulence factor for all
isolates, it remains to be established if other surface-associated
proteins are also glycosylated with the products of this locus,
thereby allowing the novel glycan structure to play a role in
colonization during infection.
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